alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid has been researched along with cfm 2 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brocke, K; Gratopp, A; Ikonomidou, C; Pohl, EE; Rzeski, W; Sifringer, M; Stepulak, A; Turski, L | 1 |
1 other study(ies) available for alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid and cfm 2
| Article | Year |
|---|---|
AMPA antagonists inhibit the extracellular signal regulated kinase pathway and suppress lung cancer growth.
Topics: Adenocarcinoma; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Antineoplastic Agents; Benzodiazepines; Benzodiazepinones; Cell Cycle; Cell Line, Tumor; Drug Screening Assays, Antitumor; Enzyme Activation; Excitatory Amino Acid Antagonists; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Neoplasm Proteins; Phosphorylation; Protein Processing, Post-Translational; Receptors, AMPA; Signal Transduction | 2007 |